The emerging nature of Ubiquitin-specific protease 7 (USP7): a new target in cancer therapy
Lauraine Nininahazwe1, Bingrui Liu2, Chenghua He3
1Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education, Co-innovation Center of Henan Province for New Drug R & D and Preclinical Safety, and School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, Henan 450001, China.
Abstract:
Human ubiquitin-specific protease 7 (USP7) is a deubiquitinating enzyme that removes the ubiquitin (Ub) protein and spares substrates from degradation. Given its regulation of proteins involved in several cellular processes, abnormal expression and activity of USP7 are associated with several types of disease, including cancer. In this review, we summarize the developments in our understanding of USP7 over the past 5 years, focusing on its role in related cancers. Furthermore, we discuss clinical studies of USP7, including in vivo and pharmacological studies, as well as the development of USP7 inhibitors. A comprehensive understanding of USP7 will expand our knowledge of the structure and function of USP7-mediated signaling and shed light on drug discovery for different diseases in which USP7 is implicated.
Insights
Human ubiquitin-specific protease 7 (USP7) deubiquitinates proteins, impacting cancer. This review covers recent USP7 research, its role in cancers, and the development of USP7 inhibitors for drug discovery.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Human ubiquitin-specific protease 7 (USP7) is a deubiquitinating enzyme crucial for protein regulation.
- USP7 activity is implicated in various cellular processes and diseases, notably cancer.
- Dysregulation of USP7 contributes to tumorigenesis and disease progression.
Purpose of the Study:
- To review recent advancements in understanding USP7 function over the past five years.
- To focus on the specific role of USP7 in various cancer types.
- To discuss clinical studies, pharmacological investigations, and the development of USP7 inhibitors.
Main Methods:
- Literature review of recent scientific publications (last 5 years).
- Analysis of studies focusing on USP7's role in cancer biology.
- Examination of clinical, in vivo, and pharmacological data related to USP7.
Main Results:
- USP7 plays a significant role in regulating proteins involved in cancer development.
- Recent studies have elucidated USP7's specific mechanisms in different cancer types.
- Development of USP7 inhibitors shows promise for therapeutic interventions.
Conclusions:
- A deeper understanding of USP7 is essential for comprehending USP7-mediated signaling pathways.
- Targeting USP7 offers a potential therapeutic strategy for various cancers.
- Further research into USP7 structure and function will drive drug discovery efforts.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...


